Door annelies_verachtert op Zat, 30/08/2014 - 00:00
Abstract: We conducted this study with the aim of demonstrating the feasibility and efficacy of speed- feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients.
Abstract: A high percentage of employed breast cancer patients returned to work after treatment, and workplace accommodations played an important role in their return. In addition, perceived employer discrimination because of cancer was negatively associated with return to work for breast cancer survivors. Employers seem to have a pivotal role in breast cancer patients’ successful return to work.
Naast de primaire en secundaire preventie merken we dat er een grote weg is vrijgemaakt voor de tertiaire preventie, dankzij de betere overlevingskansen voor de oncologische patiëntenpopulatie. Patiënten hebben lange tijd na de behandelingen nog fysieke en psychische restklachten die hun levenskwaliteit aantasten. Het is net op dat punt dat psychosociale interventies zich kunnen enten. Het aanbieden van een gestructureerd groepsprogramma kan zorgen voor een verbetering van de levenskwaliteit en de barrières wegnemen voor patiënten om te bewegen.
Door annelies_verachtert op Ma, 30/06/2014 - 00:00
Abstract: This secondary analysis of data from a randomised controlled trial explores associations between common symptom clusters and evaluates pre-treatment to post-treatment changes in clinical levels of these symptoms following cognitive behaviour therapy for insomnia (CBT-I).
Door annelies_verachtert op Ma, 30/06/2014 - 00:00
Abstract:This study examined whether workplace support, sociodemographic factors and co- morbidity are associated with early retirement or non-employment due to other reasons among breast cancer survivors. We also compared quality of life and chronic symptoms (pain, fatigue, anxiety and depression) among employed, retired and other non-employed breast cancer survivors.
Door annelies_verachtert op Ma, 30/06/2014 - 00:00
Abstract: Longitudinal neuropsychological assessments were performed to determine if adjuvant chemotherapy was associated with cognitive dysfunction in men with non-seminomatous germ cell tumors (NSGCT).
Methods: Patients with NSGCT status post-orchiectomy that either received adjuvant chemotherapy (n = 55) or did not (n = 14) were recruited. Patients were tested before chemotherapy, 1 week post- chemotherapy (or 3 months later in the surveillance group) and 12 months after the baseline evaluation.
